Press Releases

Want to know the latest about PrimeraDx? Visit our press room often to learn the latest developments about our growing company, including speaking engagements and conference and trade show exhibitions.


Mar 26th

PrimeraDx to Co-Develop Companion Diagnostics with Quest Diagnostics


Oct 3rd

FierceMedicalDevices Names PrimeraDx as one of its “Fierce 15” Medical Device and Diagnostic Companies of 2012

Sep 25th

National Cancer Institute Awards PrimeraDx Grant to Develop B-Cell Lymphoma Panel on ICEPlex System

Sep 12th

PrimeraDx Receives CE Marks for the ICEPlex System and C. difficile Detection Assay

Jun 26th

PrimeraDx Announces Commencement of Product Development Collaboration with Eli Lilly and Company

Jan 18th

PrimeraDx Receives ISO 13485:2003 Certification

Jan 3rd

PrimeraDx Appoints David Jackson as VP of Business Development


Dec 6th

PrimeraDx Appoints Leroy Hood to its Scientific Advisory Board

Dec 1st

PrimeraDx Appoints David Heffelfinger as VP of Engineering and Systems Development

Sep 22nd

PrimeraDx Appoints Albert A. Luderer to its Board of Directors

Aug 23rd

PrimeraDx Launches the Only System Capable of Simultaneous Quantification of mRNA, microRNA, and DNA

Aug 2nd

PrimeraDx Names Fayyaz Memon, Vice President of Regulatory Affairs and Quality Assurance


Aug 30th

PrimeraDx Names Matthew F. McManus, M.D., Ph.D., President and Chief Executive Officer

Mar 22nd

PrimeraDx Announces the Expansion of its Senior Management Team


Oct 5th

PrimeraDx Awarded 4th Patent Covering STAR Technology

Sep 7th

PrimeraDx closes $20m Series C

Jan 7th

PrimeraDx announces the Expansion of its Senior Management Team


Dec 1st

PrimeraDx Appoints Ted Myles as Chief Financial Officer

Jul 14th

PrimeraDx Appoints George N. Serbedzija as Vice President of Business Development

May 24th

PrimeraDx Receives Issuance of Key Patent

Feb 24th

PrimeraDx Names Robert J. Rosenthal, Ph.D., Director to the Board

Jan 7th

Primera Raises $21M in Series B funding


Aug 23rd

Primera Biosystems Introduces ViraQuant™ – The First Multiplexed Quantitative Viral Test for the Simultaneous Detection of CMV, EBV, BKV, HHV6 and HHV7

Mar 20th

PrimeraDx Names Martin L. Verhoef President and Chief Executive Officer